Xi Y - Search Results

1

Preliminary study of apatinib combined with fluzoparib in the treatment of HRP ovarian cancer via the HR pathway.

Gao L, Wang S, Hu X, Wang L, Xi Y, Bu P, Zhao G, Zhao L, Yang Y, Zhao H. Gao L, et al. Among authors: xi y. Transl Cancer Res. 2025 Apr 30;14(4):2470-2482. doi: 10.21037/tcr-2025-666. Epub 2025 Apr 27. Transl Cancer Res. 2025. PMID: 40386258 Free PMC article.

2

[Study on the origin of H/RS cell and their biological behavior in Hodgkin lymphoma by using multiple mark techniques].

Wang JF, Xi YF, Wang LX, Yin WD, Zhang JW, Gong FC. Wang JF, et al. Zhonghua Xue Ye Xue Za Zhi. 2004 Oct;25(10):579-82. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15634588 Chinese.

3

[Significance of CXCL12/CXCR4 expression in T-lymphoblastic lymphoma/leukemia].

Yu ZZ, Xi YF, Li J, Bai WQ, Gao N, Bu P. Yu ZZ, et al. Among authors: xi yf. Zhonghua Bing Li Xue Za Zhi. 2016 Dec 8;45(12):838-843. doi: 10.3760/cma.j.issn.0529-5807.2016.12.005. Zhonghua Bing Li Xue Za Zhi. 2016. PMID: 28056298 Chinese.

4

Correlation between tumor microenvironment-associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer.

Zhang S, Bai W, Tong X, Bu P, Xu J, Xi Y. Zhang S, et al. Among authors: xi y. Oncol Lett. 2019 Jan;17(1):1062-1070. doi: 10.3892/ol.2018.9682. Epub 2018 Nov 9. Oncol Lett. 2019. PMID: 30655866 Free PMC article.

5

[Expression of costimulatory molecules B7H3 and B7H4 in T lymphoblastic lymphoma/leukemia and clinical significance].

Zhang GZ, Li J, Bai WQ, Bu P, Wang HW, Xi YF. Zhang GZ, et al. Among authors: xi yf. Zhonghua Bing Li Xue Za Zhi. 2019 May 8;48(5):352-357. doi: 10.3760/cma.j.issn.0529-5807.2019.05.004. Zhonghua Bing Li Xue Za Zhi. 2019. PMID: 31104673 Chinese.

6

[Expression of CDK6 and FOXM1 in peripheral T-cell lymphoma and their significance].

Feng HN, Shao XX, Bu P, Zhang F, Wang YJ, Xi YF, Guo WN. Feng HN, et al. Among authors: xi yf. Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):594-600. doi: 10.3760/cma.j.cn112151-20191104-00710. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32486537 Chinese.

7

Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women.

Lian J, Xu EW, Xi YF, Wang HW, Bu P, Wang JF, Wang LX. Lian J, et al. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820950832. doi: 10.1177/1533033820950832. Technol Cancer Res Treat. 2020. PMID: 33047659 Free PMC article.

8

[Expression of GATA3 and bcl-11b in peripheral T-cell lymphoma and their clinical significance].

Wang YJ, Zhang HL, Li J, Bu P, Zhang F, Xi YF. Wang YJ, et al. Among authors: xi yf. Zhonghua Bing Li Xue Za Zhi. 2021 Aug 8;50(8):904-909. doi: 10.3760/cma.j.cn112151-20201224-00955. Zhonghua Bing Li Xue Za Zhi. 2021. PMID: 34344074 Chinese.

9

Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.

Lian J, Wang LX, Guo JH, Bu P, Xi YF, Yun KM. Lian J, et al. Diagn Pathol. 2021 Oct 10;16(1):89. doi: 10.1186/s13000-021-01156-6. Diagn Pathol. 2021. PMID: 34629079 Free PMC article. Review.

10

Subclassifying triple-negative breast cancers and its potential clinical utility.

Lian J, Ma HX, Xu EW, Bu P, Yun KM, Xi YF. Lian J, et al. Virchows Arch. 2022 Jul;481(1):13-21. doi: 10.1007/s00428-022-03329-0. Epub 2022 Apr 26. Virchows Arch. 2022. PMID: 35471664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,932 results

Search Page

Filters